Astrana Health (NASDAQ:ASTH) Issues FY24 Earnings Guidance

Astrana Health (NASDAQ:ASTHGet Free Report) updated its FY24 earnings guidance on Tuesday. The company provided EPS guidance of $1.28 to $1.52 for the period, compared to the consensus EPS estimate of $1.60. The company issued revenue guidance of $1.65 billion to $1.85 billion, compared to the consensus revenue estimate of $1.76 billion.

Astrana Health Trading Down 1.0 %

NASDAQ:ASTH traded down $0.39 during mid-day trading on Tuesday, hitting $37.93. 125,521 shares of the company’s stock traded hands, compared to its average volume of 153,978. The company has a market capitalization of $2.13 billion, a price-to-earnings ratio of 28.74, a price-to-earnings-growth ratio of 1.20 and a beta of 1.12. The firm’s 50 day moving average price is $40.47. The company has a quick ratio of 2.11, a current ratio of 2.11 and a debt-to-equity ratio of 0.42. Astrana Health has a 12 month low of $28.86 and a 12 month high of $45.71.

Astrana Health (NASDAQ:ASTHGet Free Report) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.09. Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The company had revenue of $353.00 million for the quarter, compared to the consensus estimate of $341.17 million. During the same quarter in the previous year, the firm posted $0.02 EPS. The business’s revenue was up 20.0% compared to the same quarter last year. As a group, equities research analysts expect that Astrana Health will post 1.65 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on ASTH shares. Jefferies Financial Group initiated coverage on Astrana Health in a research report on Monday, February 26th. They set a buy rating and a $50.00 price objective on the stock. Truist Financial boosted their price target on shares of Astrana Health from $41.00 to $44.00 and gave the company a hold rating in a report on Friday, March 1st.

View Our Latest Analysis on ASTH

About Astrana Health

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Articles

Earnings History and Estimates for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.